The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
IVD Antibodies-Global Market Insights and Sales Trends 2024
Synopsis
In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.
The global IVD Antibodies market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of IVD Antibodies in various end use industries. The expanding demands from the Hospital, Specialty Clinic, Diagnostic Center and Others, are propelling IVD Antibodies market. Cardiac Markers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tumor Markers segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for IVD Antibodies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global IVD Antibodies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global IVD Antibodies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, IVD Antibodies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of IVD Antibodies covered in this report include Abcam, Thermo Fisher Scientific, Rockland Immunochemicals, GenScript, Bio-Rad Laboratories, SDIX, MEDICAL & BIOLOGICAL LABORATORIES, HyTest and Abbott, etc.
The global IVD Antibodies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abcam
Thermo Fisher Scientific
Rockland Immunochemicals
GenScript
Bio-Rad Laboratories
SDIX
MEDICAL & BIOLOGICAL LABORATORIES
HyTest
Abbott
Global IVD Antibodies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global IVD Antibodies market, Segment by Type:
Cardiac Markers
Tumor Markers
Kidney Injury Markers
Global IVD Antibodies market, by Application
Hospital
Specialty Clinic
Diagnostic Center
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of IVD Antibodies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.
The global IVD Antibodies market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of IVD Antibodies in various end use industries. The expanding demands from the Hospital, Specialty Clinic, Diagnostic Center and Others, are propelling IVD Antibodies market. Cardiac Markers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tumor Markers segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for IVD Antibodies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global IVD Antibodies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global IVD Antibodies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, IVD Antibodies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of IVD Antibodies covered in this report include Abcam, Thermo Fisher Scientific, Rockland Immunochemicals, GenScript, Bio-Rad Laboratories, SDIX, MEDICAL & BIOLOGICAL LABORATORIES, HyTest and Abbott, etc.
The global IVD Antibodies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abcam
Thermo Fisher Scientific
Rockland Immunochemicals
GenScript
Bio-Rad Laboratories
SDIX
MEDICAL & BIOLOGICAL LABORATORIES
HyTest
Abbott
Global IVD Antibodies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global IVD Antibodies market, Segment by Type:
Cardiac Markers
Tumor Markers
Kidney Injury Markers
Global IVD Antibodies market, by Application
Hospital
Specialty Clinic
Diagnostic Center
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of IVD Antibodies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of IVD Antibodies
1.1 IVD Antibodies Market Overview
1.1.1 IVD Antibodies Product Scope
1.1.2 IVD Antibodies Market Status and Outlook
1.2 Global IVD Antibodies Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global IVD Antibodies Market Size by Region (2018-2029)
1.4 Global IVD Antibodies Historic Market Size by Region (2018-2023)
1.5 Global IVD Antibodies Market Size Forecast by Region (2024-2029)
1.6 Key Regions, IVD Antibodies Market Size (2018-2029)
1.6.1 North America IVD Antibodies Market Size (2018-2029)
1.6.2 Europe IVD Antibodies Market Size (2018-2029)
1.6.3 Asia-Pacific IVD Antibodies Market Size (2018-2029)
1.6.4 Latin America IVD Antibodies Market Size (2018-2029)
1.6.5 Middle East & Africa IVD Antibodies Market Size (2018-2029)
2 IVD Antibodies Market by Type
2.1 Introduction
2.1.1 Cardiac Markers
2.1.2 Tumor Markers
2.1.3 Kidney Injury Markers
2.2 Global IVD Antibodies Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global IVD Antibodies Historic Market Size by Type (2018-2023)
2.2.2 Global IVD Antibodies Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America IVD Antibodies Revenue Breakdown by Type (2018-2029)
2.3.2 Europe IVD Antibodies Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific IVD Antibodies Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America IVD Antibodies Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa IVD Antibodies Revenue Breakdown by Type (2018-2029)
3 IVD Antibodies Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Specialty Clinic
3.1.3 Diagnostic Center
3.1.4 Others
3.2 Global IVD Antibodies Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global IVD Antibodies Historic Market Size by Application (2018-2023)
3.2.2 Global IVD Antibodies Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America IVD Antibodies Revenue Breakdown by Application (2018-2029)
3.3.2 Europe IVD Antibodies Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific IVD Antibodies Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America IVD Antibodies Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa IVD Antibodies Revenue Breakdown by Application (2018-2029)
4 IVD Antibodies Competition Analysis by Players
4.1 Global IVD Antibodies Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in IVD Antibodies as of 2022)
4.3 Date of Key Players Enter into IVD Antibodies Market
4.4 Global Top Players IVD Antibodies Headquarters and Area Served
4.5 Key Players IVD Antibodies Product Solution and Service
4.6 Competitive Status
4.6.1 IVD Antibodies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abcam
5.1.1 Abcam Profile
5.1.2 Abcam Main Business
5.1.3 Abcam IVD Antibodies Products, Services and Solutions
5.1.4 Abcam IVD Antibodies Revenue (US$ Million) & (2018-2023)
5.1.5 Abcam Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific IVD Antibodies Products, Services and Solutions
5.2.4 Thermo Fisher Scientific IVD Antibodies Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Rockland Immunochemicals
5.3.1 Rockland Immunochemicals Profile
5.3.2 Rockland Immunochemicals Main Business
5.3.3 Rockland Immunochemicals IVD Antibodies Products, Services and Solutions
5.3.4 Rockland Immunochemicals IVD Antibodies Revenue (US$ Million) & (2018-2023)
5.3.5 GenScript Recent Developments
5.4 GenScript
5.4.1 GenScript Profile
5.4.2 GenScript Main Business
5.4.3 GenScript IVD Antibodies Products, Services and Solutions
5.4.4 GenScript IVD Antibodies Revenue (US$ Million) & (2018-2023)
5.4.5 GenScript Recent Developments
5.5 Bio-Rad Laboratories
5.5.1 Bio-Rad Laboratories Profile
5.5.2 Bio-Rad Laboratories Main Business
5.5.3 Bio-Rad Laboratories IVD Antibodies Products, Services and Solutions
5.5.4 Bio-Rad Laboratories IVD Antibodies Revenue (US$ Million) & (2018-2023)
5.5.5 Bio-Rad Laboratories Recent Developments
5.6 SDIX
5.6.1 SDIX Profile
5.6.2 SDIX Main Business
5.6.3 SDIX IVD Antibodies Products, Services and Solutions
5.6.4 SDIX IVD Antibodies Revenue (US$ Million) & (2018-2023)
5.6.5 SDIX Recent Developments
5.7 MEDICAL & BIOLOGICAL LABORATORIES
5.7.1 MEDICAL & BIOLOGICAL LABORATORIES Profile
5.7.2 MEDICAL & BIOLOGICAL LABORATORIES Main Business
5.7.3 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Products, Services and Solutions
5.7.4 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Revenue (US$ Million) & (2018-2023)
5.7.5 MEDICAL & BIOLOGICAL LABORATORIES Recent Developments
5.8 HyTest
5.8.1 HyTest Profile
5.8.2 HyTest Main Business
5.8.3 HyTest IVD Antibodies Products, Services and Solutions
5.8.4 HyTest IVD Antibodies Revenue (US$ Million) & (2018-2023)
5.8.5 HyTest Recent Developments
5.9 Abbott
5.9.1 Abbott Profile
5.9.2 Abbott Main Business
5.9.3 Abbott IVD Antibodies Products, Services and Solutions
5.9.4 Abbott IVD Antibodies Revenue (US$ Million) & (2018-2023)
5.9.5 Abbott Recent Developments
6 North America
6.1 North America IVD Antibodies Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe IVD Antibodies Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific IVD Antibodies Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America IVD Antibodies Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa IVD Antibodies Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 IVD Antibodies Market Dynamics
11.1 IVD Antibodies Industry Trends
11.2 IVD Antibodies Market Drivers
11.3 IVD Antibodies Market Challenges
11.4 IVD Antibodies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
